DK1211318T3 - Paramyxovira omfattende en modificeret transkriptionsstartsekvens - Google Patents

Paramyxovira omfattende en modificeret transkriptionsstartsekvens

Info

Publication number
DK1211318T3
DK1211318T3 DK00956962T DK00956962T DK1211318T3 DK 1211318 T3 DK1211318 T3 DK 1211318T3 DK 00956962 T DK00956962 T DK 00956962T DK 00956962 T DK00956962 T DK 00956962T DK 1211318 T3 DK1211318 T3 DK 1211318T3
Authority
DK
Denmark
Prior art keywords
sequence
gene
vectors
expression
transcription
Prior art date
Application number
DK00956962T
Other languages
English (en)
Inventor
Yoshiyuki Nagai
Atsushi Kato
Mamoru Hasegawa
Original Assignee
Dnavec Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnavec Research Inc filed Critical Dnavec Research Inc
Application granted granted Critical
Publication of DK1211318T3 publication Critical patent/DK1211318T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18822—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18841—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18843—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK00956962T 1999-09-06 2000-09-06 Paramyxovira omfattende en modificeret transkriptionsstartsekvens DK1211318T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25223199 1999-09-06
PCT/JP2000/006051 WO2001018223A1 (en) 1999-09-06 2000-09-06 Paramyxoviruses having modified transcription initiation sequence

Publications (1)

Publication Number Publication Date
DK1211318T3 true DK1211318T3 (da) 2007-11-12

Family

ID=17234351

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00956962T DK1211318T3 (da) 1999-09-06 2000-09-06 Paramyxovira omfattende en modificeret transkriptionsstartsekvens

Country Status (13)

Country Link
US (1) US7144579B2 (da)
EP (1) EP1211318B1 (da)
JP (1) JP3748535B2 (da)
KR (1) KR100776086B1 (da)
CN (1) CN1367839A (da)
AT (1) ATE369435T1 (da)
AU (1) AU6872000A (da)
CA (1) CA2376106A1 (da)
DE (1) DE60035885T2 (da)
DK (1) DK1211318T3 (da)
ES (1) ES2288866T3 (da)
HK (1) HK1047450A1 (da)
WO (1) WO2001018223A1 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6490775B1 (en) * 1999-04-23 2002-12-10 Veri-Tek Inc. Press operation verification system
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
US7226786B2 (en) * 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
US7314614B1 (en) 1999-11-02 2008-01-01 Dnavec Research, Inc. Recombinant sendai virus vector for introducing exogenous genes to airway epithelia
HK1047959A1 (en) * 2000-01-19 2003-03-14 Dnavec Research Inc. Use of paramyxovirus vector in gene transfer into blood vessel
JPWO2001072340A1 (ja) 2000-03-30 2004-01-08 株式会社ディナベック研究所 センダイウイルスベクターを用いたａｉｄｓウイルスワクチン
AU2001262684A1 (en) * 2000-06-01 2001-12-11 Dnavec Research Inc. Pseudo-type retrovirus vector containing membrane protein having hemagglutinin activity
WO2002000264A1 (en) * 2000-06-27 2002-01-03 Dnavec Research Inc. Virus vector for transferring gene into renal cells
KR20030042003A (ko) * 2000-10-06 2003-05-27 가부시키가이샤 디나벡크 겐큐쇼 골격근에 외래유전자를 도입하기 위한 파라믹소바이러스 벡터
JP2002142770A (ja) * 2000-11-08 2002-05-21 Dnavec Research Inc 循環系への遺伝子送達用パラミクソウイルスベクター
JPWO2003029475A1 (ja) * 2001-09-28 2005-01-20 株式会社ディナベック研究所 エピトープ結合β２ｍをコードする哺乳動物細胞感染性ウイルスベクターおよびその利用
CA2484287A1 (en) * 2002-04-30 2003-11-13 Dnavec Research Inc. Pharmaceutical- or gene-carrier compositions with reduced hemagglutinating activity
JPWO2004022731A1 (ja) * 2002-09-04 2005-12-22 株式会社ディナベック研究所 シアル酸結合活性を有する膜蛋白質をエンベロープに含むウイルスベクターをグラム陽性菌由来ノイラミニダーゼを用いて製造する方法
AU2003268721A1 (en) * 2002-10-01 2004-04-23 Dnavec Research Inc. Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity
CA2503317A1 (en) * 2002-10-24 2004-05-06 Dnavec Research Inc. Method of transferring gene into t cells
CN1768145A (zh) * 2003-01-31 2006-05-03 株式会社载体研究所 编码核酶的副粘病毒载体及其应用
KR20060028432A (ko) * 2003-06-30 2006-03-29 가부시키가이샤 디나벡크 겐큐쇼 고변이영역이 개변된 유전자를 탑재하는 마이너스가닥 ｒｎａ 바이러스 벡터
JP4999330B2 (ja) 2004-01-22 2012-08-15 株式会社ディナベック研究所 サイトメガロウイルスエンハンサーおよびニワトリβ−アクチンプロモーターを含むハイブリッドプロモーターを利用したマイナス鎖ＲＮＡウイルスベクターの製造方法
JPWO2005071085A1 (ja) * 2004-01-22 2007-09-06 株式会社ディナベック研究所 ウイルスベクターの製造方法
WO2006134917A1 (ja) 2005-06-14 2006-12-21 Dnavec Corporation 抗体の作製方法
DK1950307T3 (da) * 2005-10-28 2016-02-15 Id Pharma Co Ltd Genoverførsel til luftvejsepitelstamcelle ved anvendelse af en lentivirusvektor, som er pseudo-typificeret med RNA-virus-spike-protein
CA2636600A1 (en) 2006-01-17 2007-07-26 Dnavec Corporation Novel protein expression system
CA2654033A1 (en) 2006-05-31 2007-12-06 Dnavec Corporation Therapeutic agent for alzheimer's disease
JPWO2008096811A1 (ja) 2007-02-07 2010-05-27 ディナベック株式会社 弱毒化マイナス鎖ｒｎａウイルス
US9145564B2 (en) * 2007-04-13 2015-09-29 National Institute Of Advanced Industrial Science And Technology Persistently infective Sendai virus vector
US20100203027A1 (en) 2007-04-27 2010-08-12 Kyushu Univeristy National University Viral vector for gene therapy
US9127256B2 (en) 2008-07-16 2015-09-08 Dnavec Corporation Method for production of reprogrammed cell using chromosomally unintegrated virus vector
JPWO2010050586A1 (ja) 2008-10-31 2012-03-29 ディナベック株式会社 組み換え蛋白質の発現を増強する方法
EP2522360B1 (en) 2010-01-08 2016-11-16 Kyoto University Vaccine for treatment of tauopathy
CA2809515A1 (en) 2010-08-30 2012-03-08 Dnavec Corporation Composition for inducing pluripotent stem cell, and use thereof
US10975358B2 (en) 2013-09-24 2021-04-13 Id Pharma Co., Ltd. Method for improving efficiency of inducing pluripotent stem cell
JP7150241B2 (ja) 2016-11-17 2022-10-11 国立感染症研究所長 非感染性パラミクソウイルス粒子を用いた感染症ワクチン
JP6947825B2 (ja) 2017-07-21 2021-10-13 株式会社 アイロムグループ 標的配列を改変するためのポリヌクレオチドおよびその使用
EP3744847A4 (en) 2018-01-22 2021-12-08 Japan as Represented by The Director-General of National Institute of Infectious Diseases SELECTIVE CD8 POSITIVE T CELL INDUCING VACCINE ANTIGEN
CN111733170A (zh) * 2020-07-01 2020-10-02 青岛农业大学 一种表达荧光素酶的重组犬麻疹病毒
EP4209593A4 (en) 2020-09-04 2024-10-09 Heartseed Inc. IPS CELL QUALITY IMPROVING AGENT, METHOD FOR PRODUCING IPS CELLS, IPS CELLS, AND COMPOSITION FOR PRODUCING IPS CELLS
JPWO2022138964A1 (da) 2020-12-25 2022-06-30

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0864645T3 (da) * 1995-10-31 2005-10-24 Dnavec Research Inc Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet
DK0863202T3 (da) * 1995-11-01 2010-09-27 Dnavec Research Inc Rekombinant Sendai-virus
EP0912724B1 (en) * 1996-07-15 2009-12-09 The Government of The United States of America, as represented by The Department of Health and Human Services Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
US6828138B1 (en) * 1998-08-11 2004-12-07 Dnavec Research Inc. Recombinant sendai virus vector including a gene encoding a chemokine
US7226786B2 (en) * 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
HK1047959A1 (en) * 2000-01-19 2003-03-14 Dnavec Research Inc. Use of paramyxovirus vector in gene transfer into blood vessel
JPWO2001072340A1 (ja) * 2000-03-30 2004-01-08 株式会社ディナベック研究所 センダイウイルスベクターを用いたａｉｄｓウイルスワクチン
CA2322057A1 (en) * 2000-05-18 2001-11-18 Dnavec Research Inc. Paramyxovirus vectors used for transfer of foreign genes
AU2001262684A1 (en) * 2000-06-01 2001-12-11 Dnavec Research Inc. Pseudo-type retrovirus vector containing membrane protein having hemagglutinin activity
WO2002000264A1 (en) 2000-06-27 2002-01-03 Dnavec Research Inc. Virus vector for transferring gene into renal cells
KR20030042003A (ko) 2000-10-06 2003-05-27 가부시키가이샤 디나벡크 겐큐쇼 골격근에 외래유전자를 도입하기 위한 파라믹소바이러스 벡터
JP2002142770A (ja) 2000-11-08 2002-05-21 Dnavec Research Inc 循環系への遺伝子送達用パラミクソウイルスベクター
AU2002224113A1 (en) * 2000-11-27 2002-06-03 Dnavec Research Inc. Paramyxovirus vector encoding angiogenesis gene and utilization thereof

Also Published As

Publication number Publication date
EP1211318A1 (en) 2002-06-05
WO2001018223A1 (en) 2001-03-15
HK1047450A1 (zh) 2003-02-21
JP3748535B2 (ja) 2006-02-22
CA2376106A1 (en) 2001-03-15
KR100776086B1 (ko) 2007-11-15
US20040121308A1 (en) 2004-06-24
DE60035885D1 (de) 2007-09-20
CN1367839A (zh) 2002-09-04
EP1211318A4 (en) 2003-08-13
AU6872000A (en) 2001-04-10
ES2288866T3 (es) 2008-02-01
US7144579B2 (en) 2006-12-05
EP1211318B1 (en) 2007-08-08
ATE369435T1 (de) 2007-08-15
DE60035885T2 (de) 2008-05-08
KR20020013565A (ko) 2002-02-20

Similar Documents

Publication Publication Date Title
DK1211318T3 (da) Paramyxovira omfattende en modificeret transkriptionsstartsekvens
WO2021155243A8 (en) Respiratory virus immunizing compositions
UA92132C2 (ru) Высокоактивные рекомбинантные вирусы гриппа для вакцин и генотерапии
TW200636070A (en) Rescue of influenza virus
DE69934885D1 (de) Neue methoden und interferon defiziente substrate zur vermehrung von viren
EA200900681A1 (ru) Композиция для лечения респираторных синцитиальных вирусов
ATE437175T1 (de) Infektiöse cdna eines zugelassenen impfstammes des masern virus. verwendung in immunogenen zusammensetzungen
Le Nouën et al. Attenuation of human respiratory viruses by synonymous genome recoding
WO2000060050A3 (en) Recombinant influenza viruses for vaccines and gene therapy
ATE172642T1 (de) Impfstoffe und verfahren zu ihrer herstellung
IL199127A (en) Promoters for expression in modified vaccinia virus ankara (mva) and vectors comprising said promoters
DE69524618D1 (de) Abgeschwächtes impf- und gentransferase-virus, verfahren zu dessen herstellung und arzneimittel, das es enthält
IL182512A0 (en) Method for producing recombinant viruses of the mononegavirales order
WO2006136448A3 (en) Attenuated sars and use as a vaccine
ATE313641T1 (de) Expression von genen im modifizierten vaccinia virus ankara durch verwendung eines cowpox ati promoter
DE60330795D1 (de) Impfstoff gegen west nile virus
EA200500547A1 (ru) Конструкции нуклеиновых кислот для экспрессии генов
WO2003072771A3 (en) Method of preparing a treatment product using a togaviridae expression construct
MX2019014819A (es) Plásmido para inserción simplificada de secuencias cortas de adn en un cistrón que codifica para una proteína de cápside potyviral y método de aplicación.
WO2004108940A3 (en) Viral genome vectors
TH80513A (th) หน่วยการแสดงออก p180